213 related articles for article (PubMed ID: 35225474)
1. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.
Gumtorntip P; Poomtavorn Y; Tanprasertkul C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Lymph Node Metastasis in Surgically Staged FIGO IA G1/G2 Endometrial Cancer With a Tumor Size of More Than 2 cm.
Boyraz G; Salman MC; Gultekin M; Basaran D; Cagan M; Ozgul N; Yuce K
Int J Gynecol Cancer; 2017 Mar; 27(3):486-492. PubMed ID: 28187095
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
[TBL] [Abstract][Full Text] [Related]
10. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
Kumar S; Mariani A; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Podratz KC; Dowdy SC
Gynecol Oncol; 2013 Sep; 130(3):441-5. PubMed ID: 23747331
[TBL] [Abstract][Full Text] [Related]
11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
12. Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
14. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
[TBL] [Abstract][Full Text] [Related]
15. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
17. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
18. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
19. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma.
Metindir J; Bilir Dilek G
J Cancer Res Clin Oncol; 2009 Jan; 135(1):125-9. PubMed ID: 18542999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]